MICHAEL MACIKOWSKI: Open Payments
NPI 1174878086 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 30 payments from 10 companies in 2025. Trend: 2023 $681 · 2024 $816 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 16 | $566 |
| BridgeBio Pharma, Inc. | 4 | $72 |
| CVRx, Inc. | 2 | $64 |
| PFIZER INC. | 2 | $48 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| ABIOMED | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: SAPIEN 3 Ultra RESILIA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Attruby, Barostim Neo System, Assure WCD, ELIQUIS, VYNDAQEL, FUROSCIX.
Industry payments across NY — which companies pay providers there.
